Homburger advised BioVersys AG on the deal. BioVersys AG, a clinical-stage biopharmaceutical company developing and commercializing novel antibacterial products for life-threatening infections domiciled in Basel, Switzerland,...
BioVersys AG’s CHF80 Million IPO On SIX Swiss Exchange
Meyer Burger Technology AG’s CHF206.75 Million Rights Offering
Homburger advised Meyer Burger on the issuance. Meyer Burger Technology AG (SIX: MBTN) announced the successful completion of its rights offering, raising gross proceeds of CHF...
Meyer Burger’s CHF 250 Million Rights Offering
Homburger AG acted as legal counsel to Meyer Burger on this transaction. Advestra and Milbank acted as legal counsel to Goldman Sachs Europe SE, Jefferies and...